logo

Bicycle Therapeutics (BCYC)



Trade BCYC now with
  Date
  Headline
3/10/2020 7:03:34 AM Bicycle Therapeutics Q4 Loss Per Share $0.25 Vs Loss $13.19 Last Year
2/25/2020 7:13:40 AM Bicycle Therapeutics Enters Strategic Collaboration With Genentech To Develop Bicycle(r)-based Immuno-oncology Therapies
11/13/2019 7:03:16 AM Bicycle Therapeutics Announces First Patient Dosed In Phase I/II Trial Of Bicycle(r) Toxin Conjugate BT5528
10/22/2019 3:08:08 AM Bicycle Therapeutics Says Expands Neuroscience Collaborations To Include Oxford Drug Discovery Institute
9/24/2019 7:08:11 AM Bicycle Therapeutics To Present Updated Data From Phase I/IIa Trial Of BT1718 At ESMO 2019 Annual Congress
5/22/2019 9:56:55 PM Bicycle Therapeutics Prices IPO Of 4.33 Mln ADSs At $14.00/ADS
5/18/2019 12:32:29 PM Biotech IPOs For The Week Ahead
  
 
>